Top Stories

Gene testing firm 23andMe trades higher after Branson SPAC merger


Anne Wojcicki, 23andMe co-founder & CEO (right) celebrates with 23andMe employees after remotely ringing the NASDAQ opening bell at the headquarters of DNA tech company 23andMe in Sunnyvale, California, U.S., June 17, 2021.

Peter DaSilva | Reuters

The newest trade in the stock market is “ME.”

Personalized medicine and at-home genetic testing kit company 23andMe went public on Thursday through a merger with a Richard Branson SPAC, VG Acquisition Corp., in a deal that raised near-$600 million and valued the company at $3.5 billion.

23andMe shares rose by 21% on the Nasdaq in its first day of trading as a public company.

Founded by Anne Wojcicki — the former spouse of Google founder Sergey…


0 0 votes
Article Rating

Federal Reserve statement June 2021 what changed

Previous article

Burger King’s chicken sandwich marks a shift in chain’s menu strategy

Next article

You may also like

Notify of
Inline Feedbacks
View all comments

More in Top Stories